Competitive Intelligence 2014: Leading Tumor Marker Diagnostics Market Players - Strategic Assessments of Major Suppliers and Emerging Market Entrants

Date: March 1, 2014
Pages: 80
Price:
US$ 2,500.00
License [?]:
Publisher: Venture Planning Group
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: 2C0DBEC3E55EN
Leaflet:

Download PDF Leaflet

Competitive Intelligence 2014: Leading Tumor Marker Diagnostics Market Players - Strategic Assessments of Major Suppliers and Emerging Market Entrants
This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include:
  • Sales
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.
Contains 80 pages
Abbott
AdnaGen
Applied Gene Technologies
Arca
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
BioRad
Cepheid
Correlogic Systems
Dako
Decode
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
GenProbe
Guided Therapeutics
Hologic
Ipsogen
Kreatech
Kyowa Medex
Life Technologies
Mackay Life Sciences
Myriad Genetics
Nanogen.Elitech
OncoLab
OrthoClinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila

Ask Your Question

Competitive Intelligence 2014: Leading Tumor Marker Diagnostics Market Players - Strategic Assessments of Major Suppliers and Emerging Market Entrants
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: